Skip to main content

Table 4 Contribution of the seven areas to the estimates of net monetary benefit by year: 1991 to 2010 (QALY value of £25,000)

From: Estimating the returns to UK publicly funded cancer-related research in terms of the net value of improved health outcomes

 

Net monetary benefit (£ million)

Year

Treatment

Screening

Smoking reduction

Total

Prostate cancer

Breast cancer

Colorectal cancer

Cervical cancer

Bowel cancer

Breast cancer

1991

8

490

-33

1729

–

7

3885

6085

1992

8

506

-35

1699

–

7

3889

6075

1993

9

485

-33

1659

–

8

3890

6018

1994

10

504

-32

1646

–

8

3894

6030

1995

9

475

-28

1592

–

8

3906

5963

1996

-3

483

-28

1609

–

9

3920

5989

1997

-3

458

-28

1546

–

11

3933

5916

1998

-3

531

-29

1447

–

10

3947

5902

1999

-10

566

-40

1374

–

9

3966

5866

2000

-15

579

-36

1350

–

9

3989

5876

2001

-25

630

-30

1310

–

9

4018

5910

2002

-8

647

-5

1283

–

9

4037

5963

2003

-14

677

24

1294

–

9

4035

6025

2004

-7

705

49

1376

–

9

4064

6195

2005

-15

694

67

1460

–

9

4099

6314

2006

-16

697

106

1484

64

9

4138

6481

2007

-23

736

149

1469

128

9

4167

6635

2008

51

786

171

1474

192

10

4192

6876

2009

46

816

178

1528

256

10

4216

7050

2010

66

854

183

1596

320

11

4253

7282

Total

65

12318

566

29927

960

179

80437

124452

  1. Abbreviation: QALY quality adjusted life year.